Structure Therapeutics Inc - American Depositary Shares — Cash Flow (NASDAQ:GPCR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities -79.49 M-116.64 M222.2 M -93.37 M Cash from investing activities -268.34 M-358.91 M89.8 M 89.8 M Cash from financing activities 451.53 M515.26 M762.52 M 762.52 M Free cash flow -81.66 M-117.93 M218.59 M -96.98 M

Noticias

Las acciones de Structure Therapeutics podrían subir con datos sobre fármaco para la obesidad, según Cantor

Acciones de Structure Therapeutics podrían subir por datos de obesidad

Structure Therapeutics shares could rise on obesity drug data, Cantor says

Citizens reduce el precio objetivo de Structure Therapeutics por expansión del pipeline

Citizens reduce precio objetivo de Structure Therapeutics por expansión

Citizens cuts Structure Therapeutics stock price target on pipeline expansion

Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?

Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026

Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin

Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)

Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?

How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report